Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Recombinant papillomavirus vaccines

Recombinant papillomavirus vaccines

US Patent 5888516 · Granted Mar 30, 1999

Estimated economic value: $211,835,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Neisseria meningitidis compositions and methods thereof2025
Immunogenic compositions for use in pneumococcal vaccines2025
Compositions and methods relating to a mutant Clostridium difficile toxin2024
Immunogenic compositions comprising conjugated capsular saccharide antigens and 2024
Neisseria meningitidis compositions and methods thereof2023
Neisseria meningitidis compositions and methods thereof2023
Compositions relating to a mutant clostridium difficile toxin and methods thereo2022
Neisseria meningitidis composition and methods thereof2022
Immunogenic compositions for use in pneumococcal vaccines2022
Compositions and methods relating to a mutant Clostridium difficile toxin2021
Compositions relating to a mutant Clostridium difficile toxin and methods thereo2021
Compositions relating to a mutant Clostridium difficile toxin and methods thereo2021